Public-registry trials using INT-210 Capsule that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis | Innatus Therapeutics (Shanghai) Co., Ltd. | Ulcerative Colitis (UC) | PHASE1 / PHASE2 | 15 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →